pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4283-1 |
Genomic Coordinates | chr7: 56955785 - 56955864 |
Description | Homo sapiens miR-4283-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
pre-miRNA | hsa-mir-4283-2 |
Genomic Coordinates | chr7: 63621090 - 63621169 |
Description | Homo sapiens miR-4283-2 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4283 | ||||||||||||||||||||||||||||||
Sequence | 11| UGGGGCUCAGCGAGUUU |27 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ARGFX | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | arginine-fifty homeobox | ||||||||||||||||||||
Transcript | NM_001012659 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ARGFX | |||||||||||||||||||||
3'UTR of ARGFX (miRNA target sites are highlighted) |
>ARGFX|NM_001012659|3'UTR 1 CCAGAGTACTAATAAATATAGATCATTTAGAAAAGTGGTCTTCTTGCCTCTTGTACATGACTGTTTTTTTCCTTTGTCTC 81 ATTTTAACCCAACATCTGGGTCTGTGTCTCTGATTTCCATGTAAATGTTGCAAAAAGAGTTTTCCAAGTAGAGCTGGGCA 161 CTACGTAATCAGCCCCACAAGTCTCCCTGAGAAGCCTGCCTAGTCCCTTTCATGGCCAATGAGACTCCAAAATTCCCTTC 241 CCAAAACTATCTTGGATTTTCTAAAAGTAGGACAGTGGTTTTGGGGGTTATCCACTTTTATTTTTTTGAAACTAGCTCTC 321 ATTCTGTCACCCAGGCTGGAATACAGTGGTACAGTCACGGCTCACAAAAGCCTTGACCTCCTGGGCTCAGGTGATCCTCC 401 CACCTCAGCCTCCTGAGTAGCTAGGACTACAGATGCTCGCCACCACACCTGGCTAATTTTTTTTTTTTGAGACTGAGTCT 481 CGCACTGTCACCCAGGGTGGAGTGCAGTGGCGGGATCTCAGCTCAGTGCAACCTCCACCTCCTGGGGTTCAAGTGATTCT 561 CCTGTGTCAGCCTCCTGAGTAGCTGGGATTACAGGCGTGTGCCACCATGCCTGGCTAACTTTTGTATTTTTAGTAGAGAC 641 GGGGTTTCACCACGTTGCCCAGGCTGGTCTTGAACTCCTGACCTCCAGTGATCCGCCTGCCTTGACCTCCCAAAGTGCTG 721 GGATTACAGACATGAGCCACCGAGCCTGGCCAATTTTTGTGTTTTTTGTAGAGACGAGGTTTTGCCATGTTGCCCAGGCT 801 GGTCTCCAACTCCTGGACTTAACGCCATCCACCTGCCACAGCCTCCCAAAGTGCTAGGAATACAGGAGTGCACCATCGCA 881 CCCGGCTGGGTTATCTAGTTTAAAAACACTTTTTTTCAAGGAAACCGAAGAAACCATCATCCACTTTTCTCTCTGTATCA 961 TTCTGATTTTAGTATATGTGTTGTGGAAGTGAGTACACTATCATCCACTTTTAATGACAGAAAGTTATAAACTTACATTT 1041 TGTTTCCAATTTTTCATTTTTTGTTTGTTATTTGTTTTTTGTAGACAGCACTCTGTCACCCAGGCTGGAGTGCAGTGGCA 1121 CCATCTTGGCTCACTGCAGCCTCTGCCTCCTGGGCTCAAACAGTCCTCCCACCTCAGCCTTCTGAGTAGCTGAGACTACA 1201 GACATGCGCCACCATGTCTGGCTAATTTTTGTATTTTTAGTGGAGATGGGGTTTCGCCTTGTTGCCCAGGCTGAATTTGG 1281 GTTTTTTTAAAATGAGACTTTCAGTCCTAATTTGAGGGGAAATTACTGTCACCACTAGTTTTAATATAGTACAATGAAAA 1361 AATAATATATATATATATAGTACAATGGTCCAGACATAATAAGAGGTGTAAAAACTATCACAGGAAGAAATAAAAACAGA 1441 TTTTTGAAGGTGAGATGATAAACTTGCAAAACTCACAAAATAAAGAGTCAAACTTTTAGAATGACAAGTTAGCATATTTT 1521 CCAGCCACATGATCAACCTACAAAATTAATACCATTTCTGAACACCAGTAATAAAGAAACATAAGGGCTGGGGGTGGTGG 1601 CTCATGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCAGGAGATTGAGACCAGCCTGACTAA 1681 CATGGTGAAATCCCGTCTCTACTAAAAATACAAAAAAAAAAAAAAAAAAAAGCCAGGCATGGTGGCACACACCTGTAATC 1761 CCAGCTACTCGGGAGGCTGAGGAAGGAGAATTGCTTGAACCTGGGAGGTGGAGGTTGCAGTGAGCTGAGGTCGCACCACT 1841 GCACTCCAGCCTGGACAACAGAGCAAGACTCTGTCTCAAAAAAAAAATAAAAAATAAAAAATAAAAAATAAAAGAAACAT 1921 AAGATAAGTACCTCTCAATGAAAAATGTAAAAGTACCTAGAAATTCACAAAAAAATTAATACCTCTGTGGAGAAAACTTC 2001 AAAACTTAAAAAAGGACATAGAAAATGTTTTGAATAGGCCAGGCGCAGTGGCTCACACCTGTAATCCCAGCACGTTGGGA 2081 GGCCAAGGCGGGCAGATCACGAGGTCAAGAGATCAAGACCATCCTGGCCAACATGGTGAAATCCTGCCTCTACTAAAAAT 2161 ACAAAAAAAAAAAAAAATTAGCTGGGCATGGTGGCACACACCTGTAGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAAT 2241 CACAAGGATTGAAACTATGCAGTGTGTTCTCCAAACATGATGGAACGAAATTAGAAATCAATAAAATTTGGGAAATTCAC 2321 AAATATGTGGATATTAAACAACACATTCCTAAATAACCAGTGGTTAAAGAGGTAATCACAGTCTGAGCAACATGGCAAAA 2401 CCCTGTGTCTACAAAAAATAAAAAATTAGCTGGGCATGACGGCCAGAGCCCATGGTCCCAGCTACTCGAGAGGCTGAGGT 2481 AAGAGCATCCCTTGAGCCACAGAGGTCGAGGCTGCAGTGAGCTGTGACTGTGCCACTGCACTCCAGCTTGAGCAACACAG 2561 TGATACTGTCTCAATAAATAAATAAATAGAAGAAATCATGAGTAAAATTGGAAAACACTTTTAACTGAAAAAAACAAAAG 2641 CACAACAAACCAAAACATGGGATGAAGCTAAATCAATGCTTAGAAGGAAATTTATAGCTTCAAATACTTATATACATATT 2721 TTTTAAAAGTAGCTTTACATAGGAAGGAAGTGGCATAGTTTTATCAATATCTGTCAAATTAAACTTCAAGGCAAAACTTT 2801 TTTATTGAGATGGAGTCTTGCTCTGTCACCCAGGCCGTGCAATCTCGGCTCACTGCAACCTCCGCCTCCTGGGTCAAATG 2881 ATTCTCCTGCTTTAGCCTCCCAAGTAGCTGGGACTACAGGTGTACGCCACCACACCCAGCTAATTTTTGTATTTTTAGTA 2961 GGGACAGGTTTTGCCATGTTGCCCAGGCTGGCCTCAAACTCCTGAGCTCAAGTGATCCTCCCGTCTCAGCCTCCCAAAGG 3041 GCTGAGATTACAGGTGTGAGCTACCTCACCTGGCCAAAACAGTTTTTTTAGAAATGAAGTATATTAGACAACAACAAAAG 3121 GAACAACTAACCTGAAATATATAATAACTTTGAACTTAAATATACTTAACAACATATACCAAAAATATATGAGGCAAATT 3201 TTAGCAAAAATTAAAATTCTTAAGAAAACTTCACTAATATATAGTCATAATGTGGTATATTCATAGAACATTCTCAATAA 3281 TTGATAATAACAGTCCAAAGAAAGCAGAAAGAAGGAAAGCCTAGAACAGAAATAAATGAAATAGAGAATAGAAAAGCAAT 3361 ACAGAAAAAAAATTATGAAATCAAAAGCTGGTTCTTTGAAAAGATCTACAAAATGGCAAACATTTAGCTAGATTGACCAC 3441 CCCCTCAAAAGACTCAAATTACTAGAATCAGAAACAAAAGTCAAGATTTTATTACCAAACTTATAGAAATAAAAATTATT 3521 AGAAAGAAATACTATGAACAATTGAATGCCAACAAATTAGATAAATGAAATGGACAAATTCCTAGGAAGACACAGAATAC 3601 CAAATCTGACTCCACAAGAAATAGATGTTGTGAATAGAGCTTGCTATGGTATGAATGTGTCCCCCACAGCTCATGCGTTG 3681 GAAACTTAATCCCCAAAGCAACAGCTTTGAGAGGTGAGACCTTTAAGGGTTACTAGGCAGAGCCCCCATGAATGGATTAA 3761 TGCCATTATTGTGGGAGTGGGTTAGTTATCTCAGAAGTGGGTTCCTGATAAAAGGATGAGTTCGGCCTTCTTCTTCCCCA 3841 AAATCTTTATCCCCACCCCCACCTCTATCTTTCTCTCTCTCTCTTACCTCCTCCTCTCCCTTCCTTCTGCCATGGGAGGA 3921 TGAAACATGAAGGCCCTGGCCAGGTGTGGCCCCTCCATCTTCCGTCTGAGACTGGAAGACTTCCCAGCCTTCAGAACTGT 4001 AAGAAATAAATCTCTCTTCATA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 503582.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Prostate Tissue | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760583. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_A
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
PAR-CLIP data was present in SRX1760639. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_A
PAR-CLIP data was present in SRX1760641. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_B
PAR-CLIP data was present in SRX1760591. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_B
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000334384.3 | 3UTR | CCCAUGAAUGGAUUAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000334384.3 | 3UTR | CCCAUGAAUGGAUUAAUGCCAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
53 hsa-miR-4283 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT083347 | E2F1 | E2F transcription factor 1 | 2 | 4 | ||||||||
MIRT120466 | U2SURP | U2 snRNP associated SURP domain containing | 2 | 4 | ||||||||
MIRT266892 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT445166 | TFPI | tissue factor pathway inhibitor | 2 | 2 | ||||||||
MIRT445906 | SLC10A3 | solute carrier family 10 member 3 | 2 | 2 | ||||||||
MIRT455530 | GJB1 | gap junction protein beta 1 | 2 | 2 | ||||||||
MIRT460172 | UNK | unkempt family zinc finger | 2 | 6 | ||||||||
MIRT461728 | SLC27A1 | solute carrier family 27 member 1 | 2 | 2 | ||||||||
MIRT465219 | TRIP10 | thyroid hormone receptor interactor 10 | 2 | 2 | ||||||||
MIRT468911 | RPS6KA4 | ribosomal protein S6 kinase A4 | 2 | 2 | ||||||||
MIRT469691 | RAB5B | RAB5B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT471050 | PIM3 | Pim-3 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT472526 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT474932 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 2 | ||||||||
MIRT486980 | STEAP3 | STEAP3 metalloreductase | 2 | 4 | ||||||||
MIRT487483 | BANP | BTG3 associated nuclear protein | 2 | 4 | ||||||||
MIRT488263 | HSP90AB1 | heat shock protein 90 alpha family class B member 1 | 2 | 8 | ||||||||
MIRT490733 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT490896 | BARHL1 | BarH like homeobox 1 | 2 | 6 | ||||||||
MIRT490909 | STRN4 | striatin 4 | 2 | 2 | ||||||||
MIRT493812 | FSCN1 | fascin actin-bundling protein 1 | 2 | 2 | ||||||||
MIRT509030 | PALM2-AKAP2 | PALM2-AKAP2 readthrough | 2 | 2 | ||||||||
MIRT509049 | AKAP2 | A-kinase anchoring protein 2 | 2 | 2 | ||||||||
MIRT509404 | MCM7 | minichromosome maintenance complex component 7 | 2 | 6 | ||||||||
MIRT523303 | HIST1H1B | histone cluster 1 H1 family member b | 2 | 2 | ||||||||
MIRT529487 | TPD52L3 | tumor protein D52 like 3 | 2 | 2 | ||||||||
MIRT529825 | ARGFX | arginine-fifty homeobox | 2 | 4 | ||||||||
MIRT542941 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT543668 | PUM1 | pumilio RNA binding family member 1 | 2 | 4 | ||||||||
MIRT546994 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | 2 | 2 | ||||||||
MIRT560377 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT561752 | PLAGL2 | PLAG1 like zinc finger 2 | 2 | 2 | ||||||||
MIRT568966 | CACNA1C | calcium voltage-gated channel subunit alpha1 C | 2 | 2 | ||||||||
MIRT569892 | ROBO4 | roundabout guidance receptor 4 | 2 | 2 | ||||||||
MIRT570097 | SCN2B | sodium voltage-gated channel beta subunit 2 | 2 | 2 | ||||||||
MIRT576503 | Slc35e2 | solute carrier family 35, member E2 | 2 | 3 | ||||||||
MIRT623795 | GK5 | glycerol kinase 5 (putative) | 2 | 2 | ||||||||
MIRT625142 | ITPRIPL1 | inositol 1,4,5-trisphosphate receptor interacting protein-like 1 | 2 | 2 | ||||||||
MIRT631438 | HSPA14 | heat shock protein family A (Hsp70) member 14 | 2 | 2 | ||||||||
MIRT633973 | SLC35E2 | solute carrier family 35 member E2 | 2 | 3 | ||||||||
MIRT634811 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 2 | ||||||||
MIRT640520 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 2 | ||||||||
MIRT644446 | ALDOC | aldolase, fructose-bisphosphate C | 2 | 2 | ||||||||
MIRT644767 | TXNRD3NB | thioredoxin reductase 3 neighbor | 2 | 2 | ||||||||
MIRT648809 | ZNF689 | zinc finger protein 689 | 2 | 2 | ||||||||
MIRT654912 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | 2 | 2 | ||||||||
MIRT670832 | SFT2D2 | SFT2 domain containing 2 | 2 | 2 | ||||||||
MIRT675826 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | 2 | 2 | ||||||||
MIRT684020 | FOLR1 | folate receptor 1 | 2 | 2 | ||||||||
MIRT698589 | TEX261 | testis expressed 261 | 2 | 2 | ||||||||
MIRT703208 | GOLGA3 | golgin A3 | 2 | 2 | ||||||||
MIRT703492 | FNDC3B | fibronectin type III domain containing 3B | 2 | 2 | ||||||||
MIRT710754 | GRID1 | glutamate ionotropic receptor delta type subunit 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|